Cargando…
Effect of renal impairment on the pharmacokinetics of prucalopride: a single- dose open-label Phase I study
OBJECTIVE: To evaluate the pharmacokinetics of prucalopride in individuals with renal impairment (RI). METHODS: This open-label Phase I study (ClinicalTrials.gov identifier: NCT01674192) enrolled men and women aged 18–75 years who were classified by renal function: normal renal function (creatinine...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529624/ https://www.ncbi.nlm.nih.gov/pubmed/23269861 http://dx.doi.org/10.2147/DDDT.S36142 |